Integer Holdings

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Integer Holdings reports robust Q4 performance and optimistic 2023 outlook

Integer Holdings' strong Q4 performance, strategic financial decisions, and optimistic 2023 outlook position the company for continued growth. Despite challenges such as supply chain issues, the company remains focused on expanding margins and driving above-market sales growth. Opportunities lie in product development, acquisitions, and efficient debt management.

Integer Holdings reports strong Q1 performance amidst growth challenges

Integer Holdings' Q1 2023 performance showcased robust sales growth and improved operating income, underpinned by recovery from delayed shipments and strong demand. The company faces challenges from supply chain disruptions and direct labor turnover but is focused on margin improvement and profit growth acceleration.
With a positive pricing environment and a pragmatic approach to challenges, Integer Holdings aims to leverage its strong product development sales and targeted organic growth to outperform the market. Managing financial pressures effectively will be crucial for sustaining growth investments and financial stability.
Overall, Integer Holdings' strategic focus on operational efficiency, market leadership through innovation, and long-term resilience positions it well to navigate challenges and capitalize on growth opportunities in the evolving healthcare industry.

Integer Holdings reports robust Q2 results and raises full-year outlook

Integer Holdings delivered strong Q2 results, showcasing robust sales growth and operational performance driven by customer demand and supply chain enhancements.
The company raised its full-year outlook, emphasizing strategic growth, margin expansion, and commitment to customer satisfaction, indicating confidence in sustained growth.
While facing challenges related to market dynamics and operational efficiency, Integer Holdings remains well-positioned to capitalize on opportunities for revenue growth and value creation.
By focusing on customer-centric strategies, operational excellence, and strategic initiatives, Integer Holdings aims to drive sustainable growth and profitability in the evolving market landscape.

Integer Holdings reports strong Q3 performance and eyes growth opportunities

Integer Holdings showcased robust financial performance in Q3, driven by strong organic sales growth and improved operating income.
While facing challenges in debt management and operational integration, the company remains well-positioned in key product lines and growth areas.
With a positive outlook for 2023 and beyond, Integer Holdings is strategically focused on capitalizing on growth opportunities and maintaining financial strength.

Integer Holdings reports strong 2023 performance and growth strategies

Integer Holdings is poised for continued growth in 2024, with a focus on acquisitions, margin expansion, and operational efficiency.
Challenges include tax-related impacts, customer inventory adjustments, and the CRM segment's growth trajectory.
Opportunities lie in strategic acquisitions, margin improvement initiatives, and the strong performance of the Neuromodulation segment.

Integer Holdings reports robust Q1 performance, eyes continued growth

Integer Holdings delivered strong financial performance in Q1 2024, with sales, operating income, and EPS showing significant growth. Despite challenges in meeting the initial profit growth target, the company remains optimistic about its growth prospects and aims to enhance shareholder value through strategic execution.

Integer Holdings excels in Q2, raises profit outlook for 2024

Integer Holdings delivered a strong Q2 performance with sales, operating income, and EPS showing significant growth. The company's financial health remains robust, with a positive outlook for the full year and opportunities for continued growth and profitability.

Integer Holdings excels in Q3, focuses on medical tech growth

Integer Holdings reported strong financial performance in Q3 2024, with notable sales and operating income growth. The company's strategic divestment, improved financial outlook, and focus on medical technology highlight a clear path for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PLANO, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for third quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, October 26, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call.

Integer Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023

Integer Holdings' (ITGR) improving non-medical sales and a solid foothold in the broader MedTech space raise optimism about the stock.

Reasons to Add Integer Holdings (ITGR) Stock to Your Portfolio

Integer Holdings has nudged past previous highs following its Q2 FY'23 numbers. Investors are paying a premium into the recent momentum at 21x forward earnings. Sentiment towards ITGR's equity stock has shifted towards the positive side.

Integer Holdings: Revised Expectations Look Well Accounted For In Price Extension

Integer Holdings' (ITGR) second-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.

Integer Holdings (ITGR) Q2 Earnings Top Estimates, FY23 View Up

Integer Holdings Corporation (NYSE:ITGR ) Q2 2023 Earnings Conference Call July 27, 2023 9:00 AM ET Company Participants Joe Dziedzic - President and Chief Executive Officer Diron Smith - VP, Financial Planning and Analysis and Interim Chief Financial Officer Andrew Senn - SVP, Strategy, Business Development and IR Conference Call Participants Matthew Mishan - KeyBanc Capital Markets Phillip Dantoin - Piper Sandler Craig Bijou - Bank of America Nathan Treybeck - Wells Fargo Operator Hello, my name is Jeremy and I'll be the conference operator today. At this time, I would like to welcome everyone to the Integer Holdings Corporation conference call.

Integer Holdings Corporation (ITGR) Q2 2023 Earnings Call Transcript

Although the revenue and EPS for Integer (ITGR) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Integer (ITGR) Q2 Earnings: A Look at Key Metrics

Integer (ITGR) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.04 per share a year ago.

Integer (ITGR) Tops Q2 Earnings and Revenue Estimates

~ Continued strong performance with 2Q23 financial results ~ ~ Increasing full year 2023 outlook ~ PLANO, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended June 30, 2023. Second Quarter 2023 Highlights (compared to Second Quarter 2022, except as noted) Sales increased 14% to $400 million, with organic growth of 14%.

Integer Holdings Corporation Reports Second Quarter 2023 Results

Globus Medical

Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Globus Medical (GMED). But which of these two stocks is more attractive to value investors?

ITGR or GMED: Which Is the Better Value Stock Right Now?

Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Integer (ITGR) to Report a Decline in Earnings: What to Look Out for

PLANO, Texas, June 29, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 27, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call.

Integer Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023

Cadence Bank

ChampionX

Columbia Banking System

Seacoast Banking Corporation of Florida

Last year marked a tumultuous period for small-cap stocks, with the MSCI USA Small Cap Index enduring a substantial setback, dropping by 17% over the year.

Relative Underperformance of Small Cap Stocks Opens Up Opportunities, Including These 10 Ideas

PLANO, Texas, June 15, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, and Andrew Senn, Senior Vice President, Strategy, Business Development, and Investor Relations, will participate in Citi's 2023 European Healthcare Conference, which will be held at the Citigroup Centre, 33 Canada Square, London, England, beginning at 8:00 a.m. British Summer Time (3:00 a.m. Eastern Time), on Tuesday, June 20, 2023.

Integer to Participate in Citi's 2023 European Healthcare Conference

Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and a solid foothold in the broader MedTech space.

Here's Why You Should Hold Integer Holdings (ITGR) Stock for Now

Hologic

Masimo

The Zacks Medical - Instruments industry is growing on rising demand for digital health. HOLX, MASI and ITGR are set to gain the most.

3 Medical Instruments Stocks to Buy Amid Industry Challenges

Integer Holdings Corporation is a $2.6-billion market cap developer and manufacturer of medical devices and components. In Q1 FY2023, the company achieved double-digit sales growth in all four product lines, driven by strong customer demand and recovery.

Integer Holdings Stock: The Risk-Reward Is Not On Your Side

Integer Holdings Corporation (NYSE:ITGR ) Q1 2023 Earnings Conference Call April 27, 2023 9:00 AM ET Company Participants Joe Dziedzic - President & CEO Jason Garland - EVP & CFO Andrew Senn - SVP, Strategy, Business Development & IR Conference Call Participants Matthew Mishan - KeyBanc Capital Markets Craig Bijou - Bank of America Phillip Dantoin - Piper Sandler Operator Thank you for standing by. My name is Michelle, and I will be your conference operator today.

Integer Holdings Corporation (ITGR) Q1 2023 Earnings Call Transcript

Integer Holdings' (ITGR) first-quarter results reflect robust Medical and Non-Medical sales, besides strength in all the product lines.

Integer Holdings (ITGR) Q1 Earnings, Revenues Beat Estimates

Integer (ITGR) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.78 per share a year ago.

Integer (ITGR) Surpasses Q1 Earnings and Revenue Estimates

~ Strong start to the year with 1Q23 financial results ~ ~ Executing strategy to accelerate growth ~ PLANO, Texas, April 27, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended March 31, 2023. First Quarter 2023 Highlights (compared to First Quarter 2022, except as noted) Sales increased 22% to $379 million, with organic growth of 21%.

Integer Holdings Corporation Reports First Quarter 2023 Results

3 Reasons to Retain Integer Holdings (ITGR) Stock for Now

PLANO, Texas, March 30, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 27, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call.

Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023

PLANO, Texas, March 09, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, and Jason Garland, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum at 10:30am ET on Tuesday, March 21, 2023.

Integer to Take Part in a Virtual Fireside Chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Integer Holdings posted growth across all core segments and vertically throughout the P&L. Aspirations for increasing operating leverage to 2x into the coming periods.

Integer Holdings: Equity Risk Premium Not Justified, Rate Hold

Integer Holdings' (ITGR) fourth-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.

News for Integer Holdings Stock (ITGR)